Preclinical Evidence That Trametinib Enhances the Response to Tyrosine Kinase Inhibitors in Acute Myeloid Leukemia

被引：1
|
作者：
Martinez-Lopez, Joaquin [1 ]
Linares, Maria [2 ]
Morales, Maria Luz [2 ]
Arenas, Alicia [1 ]
Zagorac, Ivana [3 ]
Ayala, Rosa M. [1 ]
Castro, Nerea [4 ]
Rapado, Inmaculada [5 ]
Quintela-Fandino, Miguel [3 ]
机构：
[1] Octubre Hosp, Dept Hematol, Madrid, Spain
[2] Hosp 12 Octubre, Inst Invest, Madrid, Spain
[3] Ctr Nacl Invest Oncol, Madrid, Spain
[4] Hosp Octubre, Ser Hematol, Madrid, Spain
[5] Hosp Univ 12 Octubre, Madrid, Spain
来源：
BLOOD | 2016年 / 128卷 / 22期
关键词：
D O I：
10.1182/blood.V128.22.1581.1581
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1581
引用
收藏
页数：4
相关论文
共 50 条
  • [31] Molecular monitoring in chronic myeloid leukemia - Response to tyrosine kinase inhibitors and prognostic implications
    Jabbour, Elias
    Cortes, Jorge E.
    Kantarjian, Hagop M.
    CANCER, 2008, 112 (10) : 2112 - 2118
  • [32] Prospective Biochemical Analysis of Chronic Myeloid Leukemia Patients in Response to Tyrosine Kinase Inhibitors
    Arsalan, Hafiz Muhammad
    Arif, Amina
    Khan, Muhammad Khalil Ahmad
    PAKISTAN JOURNAL OF ZOOLOGY, 2023, 55 (05) : 2103 - 2111
  • [33] Response to Tyrosine Kinase Inhibitors in Real-World Patients With Chronic Myeloid Leukemia
    Szeto, Andy H.
    Bucci, Tyler
    Deal, Allison
    Zhu, Anqi
    Ahmad, Majd
    Cass, Amanda S.
    Sketch, Margaret R.
    Kemper, Ryan
    Zeidner, Joshua F.
    Foster, Matthew C.
    Muluneh, Benyam
    Crona, Daniel J.
    ANNALS OF PHARMACOTHERAPY, 2022, 56 (07) : 753 - 763
  • [34] Assessment of molecular response to tyrosine kinase inhibitors in Tunisian Patients with Chronic Myeloid Leukemia
    Frikha, Rim
    Kassar, Olfa
    Elloumi, Moez
    Kamoun, Hassen
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2022, 28 (08) : 1826 - 1831
  • [35] Mutations of resistance to tyrosine kinase inhibitors in chronic myeloid leukemia
    Kihel, I.
    Nachi, M.
    Bekadja, M. A.
    CLINICA CHIMICA ACTA, 2022, 530 : S334 - S335
  • [36] Unplanned discontinuation of tyrosine kinase inhibitors in chronic myeloid leukemia
    Tsutsumi, Yutaka
    Ito, Shinichi
    Ohigashi, Hiroyuki
    Shiratori, Souichi
    Teshima, Takanori
    MOLECULAR AND CLINICAL ONCOLOGY, 2016, 4 (01) : 89 - 92
  • [37] Current Management of Chronic Myeloid Leukemia with Tyrosine Kinase Inhibitors
    Haznedaroglu, Ibrahim C.
    TURKISH JOURNAL OF HEMATOLOGY, 2013, 30 (03) : 247 - 255
  • [38] Chronic myeloid leukemia, tyrosine kinase inhibitors and cardiovascular system
    Malkan, U. Y.
    Haznedaroglu, I. C.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2023, 27 (12) : 5493 - 5506
  • [39] Treating Chronic Myeloid Leukemia in the Era of Tyrosine Kinase Inhibitors
    Gale, Robert Peter
    Goldman, John M.
    ACTA HAEMATOLOGICA, 2013, 130 (03) : 192 - 195
  • [40] Discontinuation of tyrosine kinase inhibitors in pediatric chronic myeloid leukemia
    Shima, Haruko
    Kada, Akiko
    Tanizawa, Akihiko
    Sato, Iori
    Tono, Chikako
    Ito, Masaki
    Yuza, Yuki
    Watanabe, Akihiro
    Kamibeppu, Kiyoko
    Uryu, Hideko
    Koh, Katsuyoshi
    Imai, Chihaya
    Yoshida, Nao
    Koga, Yuhki
    Fujita, Naoto
    Saito, Akiko M.
    Adachi, Souichi
    Ishii, Eiichi
    Shimada, Hiroyuki
    PEDIATRIC BLOOD & CANCER, 2022, 69 (08)
12345